Steven Patierno

Overview:

Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

Positions:

Professor of Medicine

Medicine, Medical Oncology
School of Medicine

Professor of Pharmacology and Cancer Biology

Pharmacology & Cancer Biology
School of Medicine

Professor in Family Medicine and Community Health

Family Medicine and Community Health
School of Medicine

Core Faculty Member, Duke-Margolis Center for Health Policy

Duke - Margolis Center For Health Policy
Institutes and Provost's Academic Units

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

B.S. 1981

University of Connecticut

Ph.D. 1985

University of Texas Medical School, Houston

Postdoctoral Training, Norris Comprehensive Cancer

University of Southern California

Grants:

3D Biology Signatures defined by Nanostring Max System

Administered By
Medicine, Medical Oncology
Awarded By
North Carolina Biotechnology Center
Role
Major User
Start Date
End Date

Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer

Administered By
Medicine, Medical Oncology
Awarded By
V Foundation for Cancer Research
Role
Significant Contributor
Start Date
End Date

PC150506: Small molecule targeting of RNA splice variants driving tumor aggressiveness

Administered By
Chemistry
Awarded By
United States Army Medical Research Acquisition Activity
Role
Collaborator
Start Date
End Date

2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership

Administered By
Duke Cancer Institute
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Detection of Novel Alternative Splicing Biomarkers of Hypoxia in Breast and Lung Tumors

Administered By
Radiation Oncology
Awarded By
Rsna Research & Education Fund
Role
Mentor
Start Date
End Date

Publications:

Abstract B064: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer

Authors
Allen, TA; Lipton, G; Sibley, AB; Healy, P; Patierno, BM; Lacroix, B; Patierno, SR; Owzar, K; Hyslop, T; George, DJ; Freedman, JA
MLA Citation
Allen, Tyler A., et al. “Abstract B064: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer.” Poster Presentations  Proffered Abstracts, American Association for Cancer Research, 2020. Crossref, doi:10.1158/1538-7755.disp19-b064.
URI
https://scholars.duke.edu/individual/pub1467278
Source
crossref
Published In
Poster Presentations Proffered Abstracts
Published Date
DOI
10.1158/1538-7755.disp19-b064

Abstract B063: Race-relatedLMO7exon skipping enhances prostate tumor invasion

Authors
MLA Citation
Al Abo, Muthana, et al. “Abstract B063: Race-relatedLMO7exon skipping enhances prostate tumor invasion.” Poster Presentations  Proffered Abstracts, American Association for Cancer Research, 2020. Crossref, doi:10.1158/1538-7755.disp19-b063.
URI
https://scholars.duke.edu/individual/pub1467297
Source
crossref
Published In
Poster Presentations Proffered Abstracts
Published Date
DOI
10.1158/1538-7755.disp19-b063

Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer

Authors
MLA Citation
LaCroix, Bonnie L., et al. “Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer.” Poster Presentations  Proffered Abstracts, American Association for Cancer Research, 2020. Crossref, doi:10.1158/1538-7755.disp19-d064.
URI
https://scholars.duke.edu/individual/pub1467298
Source
crossref
Published In
Poster Presentations Proffered Abstracts
Published Date
DOI
10.1158/1538-7755.disp19-d064

Identification of differentially expressed and spliced genes between breast, colon, lung, and prostate cancer from African American and white patients

Authors
MLA Citation
URI
https://scholars.duke.edu/individual/pub1467299
Source
wos-lite
Published In
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Volume
29
Published Date

Abstract A080: Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs

Authors
Ingraham, KL; Packenham, J; Harvey, D; Patierno, S; Barrett, NJ
MLA Citation
Ingraham, Kearston L., et al. “Abstract A080: Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs.” Poster Presentations  Proffered Abstracts, American Association for Cancer Research, 2020. Crossref, doi:10.1158/1538-7755.disp18-a080.
URI
https://scholars.duke.edu/individual/pub1467300
Source
crossref
Published In
Poster Presentations Proffered Abstracts
Published Date
DOI
10.1158/1538-7755.disp18-a080